Christine E. Foster

Array ( [id] => 2915098 [patent_doc_number] => 05234685 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-08-10 [patent_title] => 'Method of determining incompatibility-reaction-causing substances in blood products as well as a method of inactivating said incompatibility-reaction-causing substances' [patent_app_type] => 1 [patent_app_number] => 7/412999 [patent_app_country] => US [patent_app_date] => 1989-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 5283 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/234/05234685.pdf [firstpage_image] =>[orig_patent_app_number] => 412999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2823807 [patent_doc_number] => 05116732 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-05-26 [patent_title] => 'Tetrazolium halide compounds and methods' [patent_app_type] => 1 [patent_app_number] => 7/405754 [patent_app_country] => US [patent_app_date] => 1989-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2764 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/116/05116732.pdf [firstpage_image] =>[orig_patent_app_number] => 405754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2823825 [patent_doc_number] => 05116733 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-05-26 [patent_title] => 'Method of assaying target substance' [patent_app_type] => 1 [patent_app_number] => 7/396681 [patent_app_country] => US [patent_app_date] => 1989-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4427 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 314 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/116/05116733.pdf [firstpage_image] =>[orig_patent_app_number] => 396681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2881834 [patent_doc_number] => 05108933 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-04-28 [patent_title] => 'Manipulation of colloids for facilitating magnetic separations' [patent_app_type] => 1 [patent_app_number] => 7/389697 [patent_app_country] => US [patent_app_date] => 1989-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9745 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/108/05108933.pdf [firstpage_image] =>[orig_patent_app_number] => 389697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2870859 [patent_doc_number] => 05091307 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-02-25 [patent_title] => 'Procedure for the counting, detection and identification of mycoplasms in general and urinogenital mycoplasms in particular and a biological medium specially adapted to this effect' [patent_app_type] => 1 [patent_app_number] => 7/363901 [patent_app_country] => US [patent_app_date] => 1989-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3907 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 210 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/091/05091307.pdf [firstpage_image] =>[orig_patent_app_number] => 363901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2783696 [patent_doc_number] => 05093230 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-03-03 [patent_title] => 'Method for rapid and sensitive detection of IgM retroviral antibodies' [patent_app_type] => 1 [patent_app_number] => 7/365109 [patent_app_country] => US [patent_app_date] => 1989-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5243 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 226 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/093/05093230.pdf [firstpage_image] =>[orig_patent_app_number] => 365109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2812070 [patent_doc_number] => 05079140 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-01-07 [patent_title] => 'Agent for reducing ascorbic acid interference in liquid or dry phase assay systems and method relating thereto' [patent_app_type] => 1 [patent_app_number] => 7/337620 [patent_app_country] => US [patent_app_date] => 1989-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5836 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/079/05079140.pdf [firstpage_image] =>[orig_patent_app_number] => 337620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2929163 [patent_doc_number] => 05219728 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-06-15 [patent_title] => 'Soluble forms of low affinity Fc gamma receptors, process for their identification and dosage, a corresponding dosage kit, and applications' [patent_app_type] => 1 [patent_app_number] => 7/353676 [patent_app_country] => US [patent_app_date] => 1989-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 4293 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/219/05219728.pdf [firstpage_image] =>[orig_patent_app_number] => 353676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2801050 [patent_doc_number] => 05147637 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-09-15 [patent_title] => 'Method of inhibiting the influx of leukocytes into organs during sepsis or other trauma' [patent_app_type] => 1 [patent_app_number] => 7/331450 [patent_app_country] => US [patent_app_date] => 1989-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3970 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/147/05147637.pdf [firstpage_image] =>[orig_patent_app_number] => 331450 [rel_patent_id] =>[rel_patent_doc_number] =>)